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East Lansing, MichiganABSTRACT Integrins are dynamic transmembrane cation-dependent heterodimers that both anchor cells in position and
transduce signals into and out of cells. We used an atomic force microscope (AFM)-based nanorobotic system to measure in-
tegrin-binding forces in intact human intestinal epithelial Caco-2 cells. The AFM-based nanorobot enables human-directed, high-
accuracy probe positioning and site-specific investigations. Functionalizing the AFM probe with an arginine-glycine-aspartate
(RGD)-containing sequence (consensus binding sequence for integrins) allowed us to detect a series of peptide-cell membrane
interactions with a median binding force of 115.15 4.9 pN that were not detected in control interactions. Chelating divalent cat-
ions from the culture medium abolished these interactions, as did inhibiting intracellular focal adhesion kinase (FAK) using Y15.
Adding 1 mMMg2þ to the medium caused a rightward shift in the force-binding curve. Adding 1 mM Ca2þ virtually abolished the
RGD-membrane specific interactions and blocked the Mg2þ effects. Cell adhesion assays demonstrated parallel effects of diva-
lent cations and the FAK inhibitor on cell adhesion. These results demonstrate direct modulation of integrin-binding affinity by
both divalent cations and intracellular signal inhibition. Additionally, three binding states (nonspecific, specific inactivated, and
specific activated) were delineated from affinity measurements. Although other research has assumed that this process of in-
tegrin conformational change causes altered ligand binding, in this work we directly measured these three states in individual
integrins in a physiologically based study.INTRODUCTIONIntegrins are cation-dependent transmembrane dimers that
interact with extracellular matrix (ECM) proteins such as
collagen, fibronectin, vitronectin, and laminin. Integrins
are important for cell functions such as migration or
embryogenesis, and in pathophysiologic events as diverse
as leukocyte adhesion during inflammation or infection,
blood clotting, and cancer. Alterations in the functional sta-
tus of integrins in cancer facilitate metastasis (1,2). These
adhesion structures are heterodimeric proteins with diverse
a and b subunits. The specific subunit composition of
each integrin determines its functionality and specificity
(3). Integrins anchor the cell to the ECM and in some cases
to other cells, and transduce signals defined by the ECM
composition and organization into the cell (3), as well as
signals initiated by deformation of the matrix (4). An amino
acid triplet containing arginine, glycine, and glutamate is a
vital consensus feature of proteins bound by many integrin
heterodimers, including a5b1, a8b1, aVb1, aVb3, aVb5,
aVb6, aVb8, and aIIbb3 (5–8).
The binding ability of integrins is state dependent, with an
open or closed conformation that is classically believed to
depend largely on the occupancy of an extracellular divalent
cation-binding site. Mg2þ and Mn2þ are believed to main-
tain integrins in an open status, enabling them to bind to
other structures, whereas Ca2þ and Zn2þ have been hypoth-Submitted February 19, 2013, and accepted for publication May 30, 2013.
6Kevin C. Patterson and Ruiguo Yang contributed equally to this work.
*Correspondence: xin@egr.msu.edu or marc.basson@hc.msu.edu
Edtior: Levi Gheber.
 2013 by the Biophysical Society
0006-3495/13/07/0040/8 $2.00esized to stimulate a closed conformation that limits binding
interactions (9–11). Although these changes in ligand-bind-
ing force by individual integrins determine affinity, clus-
tering of integrins can increase the overall binding force,
which is described as a change in avidity. Although integrins
were originally thought to transduce signals primarily from
outside the cell, it is now becoming increasingly clear that
both affinity (12) and avidity (2,13) may be influenced by
intracellular signaling, allowing signals from within the
cell to affect external events. Several intracellular proteins,
such as focal adhesion kinase (FAK) (14,15), congregate
around the cytoplasmic domain of integrins, forming focal
adhesions. FAK is important in regulating the functional sta-
tus of integrins and mediating cell adhesion and migration,
and even plays a role in cancer progression and metastasis
(16–18). FAK also interacts with many other molecules in-
side the cell and is therefore a target for signaling and med-
ical research (14,18,19).
The atomic force microscope (AFM) has been used in
biology to characterize and interact with living cells. It uti-
lizes an ultrasharp tip attached to an accurately position-
controlled cantilever. Physical interactions between the
sample and the tip can be detected by the bending of the
cantilever. Thus, the AFM can be used to obtain topograph-
ical information down to the nanoscale. It has been used to
image structures and characterize the mechanical properties
of living cells. Additional functional capability is introduced
by attaching the tip with various chemical reagents to probe
surface interactions (20–23). In previous studies, investiga-
tors used AFM to measure the cell-ECM interface (24) andhttp://dx.doi.org/10.1016/j.bpj.2013.05.052
Modulation of Integrin Affinity with AFM Nanorobot 41integrin interactions (25,26) in living cells in various cell
lines. However, these authors did not conduct physiologi-
cally relevant experiments and did not alter the properties
of integrin binding because they utilized features such as
temperature outside of human limits.
Previous studies have approached the concept of integrin-
binding affinities on a statistical and global level (10,27).
AFM permits more specific assessment at the molecular
level of interaction. Integrin interactions with glycine-
arginine-glycine-aspartate-serine-proline (RGD)-containing
proteins were previously characterized by Sun and col-
leagues (25) using AFM, but no adjustment of the cell envi-
ronment was performed in that study. Lehenkari and Horton
(26) also used AFM to assess the integrin-RGD binding
force, but mainly altered the pH of the environment between
7.4 and 4.0 to vary the integrin-binding status of rat osteo-
clasts. Rico et al. (28) studied the effects of temperature
modification on integrin binding with AFM in leukocytes,
but the temperature changes they studied were nonphysio-
logic, comparing 37C with 24C and 17C. In addition,
leukocyte integrins represent a very different pool that is
rich in b2 subunit heterodimers compared with the hetero-
dimers of b1 and b3 chiefly expressed by epithelial cells.
In addition, assessments of surface interactions such as
binding affinity require large numbers of measurements
over random positions. However, commercial AFMs suffer
from poor positioning precision for random measurements,
since they are built to perform zig-zag scanning tasks. More-
over, the lack of human interface further undermines their
capability as a biologically intensive screening and surveying
instrument. Thus, we introduced the use of AFM-based nano-
robotics for this application by considering the AFM canti-
lever as a robotic arm (29,30). Equipped with a series of
hardware and software upgrades to a commercial AFM, one
can position the probe precisely to a desired location with
ease using a joystick through a customer-tailored external
closed-loop system for random positioning and control.
This greatly enhances the measurement capability of AFM,
especially when large numbers of measurements are required
for statistical analysis (31,32). Here, we use the AFM robotic
system to characterize the interaction betweenRGD-contain-
ing peptides and integrins, and assess the binding status in
response to different ions, ion-ion interactions, and inhibitors
of intracellular kinases. This research allows us to quantify
the changes on a nanoscale in a physiologically based process
and provide meaningful future applications. We also delin-
eate three distinct states of integrin binding and correlate
themwith conformational changes proposed in the literature.MATERIALS AND METHODS
Cell line and cell culture
Caco-2BBE cells are an enterocytically differentiated subclone of the orig-
inal Caco-2 (33). Previous work from our laboratory demonstrated thatCaco-2 cells express b1 and b3 integrin subunits in combination with the
a1, a2, a3, a5, and a6 subunits (2). The peptide used here for binding
would be expected to bind reproducibly to integrin heterodimers between
the b1 subunit and the a1–a3 subunits (34).
Caco-2 cells (ATCC, Manassas, VA) were cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM; Invitrogen, Carlsbad, CA) supplemented
with 10% heat-inactivated fetal bovine serum (Sciencell, Carlsbad, CA),
1% penicillin/streptomycin (Invitrogen), and 10 g/ml transferrin (Sigma-
Aldrich, St. Louis, MO) at 37C in a humidified 5% CO2 environment.
Caco-2 cells between passages 60 and 70 were utilized. The cells were sub-
cultured using 0.05% trypsin-EDTA solution (Invitrogen). The cells were
plated on sterilized 1-cm-diameter glass slides prepared by immersion in
12.50 mg/ml type I collagen in enzyme-linked immunosorbent assay
(ELISA) buffer (Sigma-Aldrich) overnight at 4C. Freshly passaged cells
were distributed on the glass slides and grown in standard 12-well plates
in DMEM until they were 90% confluent.Tip preparation and coating
AFM tips made of silicon nitride were used in the measurement of integrin
affinity. The AFM tip was UV-cleaned for 15 min and then coated with
polyethylene glycol (PEG; Sigma-Aldrich, St. Louis, MO) as a linker by
immersion in 1 g/ml. Next, the tip was coated in either an RGD peptide
(1 mg/mL; Sigma-Aldrich, St. Louis, MO) in Ca2þ- and Mg2þ-free phos-
phate-buffered saline (PBS) as the positive test or a glycine-arginine-
glycine-glutamate-serine-proline (RGE) peptide (1 mg/ml; AnaSpec, San
Jose, CA) in PBS as the control. The AFM tip was immersed in PEG for
20 min, washed three times with PBS, coated with RGD or RGE for
20 min, and then washed three times with PBS.Cell treatments and cation modulation
Once the Caco-2 cells attained 90% confluence, they were prepared for
measurement. Initially, the Caco-2-coated glass slides were washed three
times with PBS to remove any residual medium. For cation modulation,
the cells were allowed to equilibrate for 5 min in pH-controlled 10 mM
HEPES supplemented with either 1 mM Ca2þ, 1 mM Mg2þ, 1 mM Ca2þ
with 1 mM Mg2þ, or 1 mM of the cation chelator, EDTA. The cells were
subsequently measured by AFM using random affinity measurements
over cells, as described below.Intracellular signal modulation
We used 1,2,4,5-benzenetetraamine tetrahydrochloride (Y15; Sigma-
Aldrich) to inhibit intracellular FAK, which modulates extracellular integ-
rin-binding affinity. Y15 was diluted in PBS with 1% bovine serum albumin
(BSA). The cells were washed three times with warm PBS, pretreated in
1 mM Mg2þ in 10 mM HEPES with 20 mM Y15 or Y15 vehicle for
30 min at 37C, and then measured with AFM as described below.Global cell adhesion
Purified type I collagen was precoated at saturating densities of 12.50 ml/ml
on nontreated 24-well plates using an ELISA-based buffer overnight at 4C.
The plates were washed three times with PBS and equilibrated with 10 mM
HEPES/PBS for 30 min prior to the adhesion experiment. After attaining
90% confluence, Caco-2 cells were subcultured into T75 flasks at a concen-
tration of 500,000 cells per flask, and allowed to grow for another 48 hr. The
cells were then pretreated in either 10 mM HEPES/PBS with 1 mM Mg2þ
and 20 mM Y15, 20 mM Y15 only, or Y15 vehicle (PBS 1% BSA) for
30 min at 37C. After the pretreatment, they were trypsinized (2–3 min)
and the trypsin was neutralized with cell culture medium. The cells were
then centrifuged and resuspended in 1 mM Calcein-AM (Invitrogen) inBiophysical Journal 105(1) 40–47
42 Patterson et al.warm PBS and incubated in Calcein for 15 min at 37C. The cells were
centrifuged again and pretreated for 5 min at 37C in pH-controlled
10 mM HEPES supplemented with either 1 mM Ca2þ, 10 mM Ca2þ,
1 mM Mg2þ, 10 mM Ca2þ with 1 mM Mg2þ, 1 mM EDTA, or 1 mM
Mg2þ with 1 mM EDTA. Then 80,000 cells were added to each well and
incubated at 37C for 30 min. They were then washed twice in PBS and
read at 495 nm excitation and 519 nm emission.AFM nanorobotic measurement and force
displacement curve processing
All force measurements were performed on a customized Bioscope AFM
(Bruker Nano, Santa Barbara, CA). Silicon nitride cantilevers with a spring
constant of ~0.06 N/m were used, and each individual probe was calibrated
using the thermal tune method to get the exact value of the spring constant.
The temperature in the experimental setup was maintained at 37C by a pol-
yimide film heater, as part of the integrated AFM nanorobotic system, un-
derneath the Petri dish during the measurement. Data were sampled using
the AFM robotic system by placing the probe to a random position through
a joystick to obtain more than a hundred force-displacement curves within a
10 mm10 mm area, and then another area was selected to sample. Because
the vertical moving speed affects the measurement results, all of the mea-
surements were conducted at a loading rate of 1.2 mm/s. A data-processing
routine custom written in MATLAB (The MathWorks, Natick, MA) was
utilized to convert the force-displacement curve to an unbinding force by
detecting the largest cantilever deflection change in the pull-off phase.
The unbinding forces collected were then analyzed statistically to obtain
the frequency distribution, which was subsequently fitted with a multi-
Gaussian distribution. The distribution pattern was ultimately assessed as
an indicator of the integrin adhesion pattern.Western blot blockade of FAK
FAK inhibition was verified by western blot for FAK (Y397) phosphoryla-
tion, a key early step in FAK activation. This was achieved by inducing
FAK activation via adhesion to collagen. After 30 min of treatment in either
100 mM Y15 or Y15 vehicle at 37C, cells were trypsinized and plated on
six-well plates precoated with saturating densities of type I collagen. The
cells were then incubated at 37C for 30 min. The adherent cells were
then washed with cold PBS. Lysis buffer (50 mM Tris pH 7.4, 150 mM8
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ized with no coating (C), RGE coating (D), and RGD coating (E). (D–F) Bac
coating of the AFM probe (E), but specific activated binding is observed with R
Biophysical Journal 105(1) 40–47NaCl, 1% TritonX-100, 1% sodium deoxycholate, 0.1% sodium dodecyl
sulfate (SDS), 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mM
Na3VO4, 50 mM NaF, 10 mM sodium pyrophosphate, 2 mg/ml aprotinin,
2 mg/ml leupeptin, pH 7.4) was added to both cell populations to ensure pro-
tein preservation. Protein concentrations in the cell lysates were measured
using bicinchoninic acid (BCA) protein. Cell lysates were resolved under
reducing conditions by 10% SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) before they were transferred to nitrocellulose membranes.
Membranes were blotted with antibodies directed against the phosphory-
lated form of FAK (Y397; Cell Signaling, Beverly, MA) and with the appro-
priate secondary antibody coupled to horseradish peroxidase. Bands were
detected with enhanced chemiluminescence (GE Healthcare, Piscataway,
NJ) and analyzed with a Kodak Image Station 440CF (Eastman Kodak,
Rochester, NY). All blots were then stripped and similarly reprobed for
total FAK. All exposures used for densitometry were within the linear range
of the assay.RESULTS
Detection of single integrin binding force
The affinity measurements of a noncoated AFM probe inter-
acting with the Caco-2 cell surface exhibited a smooth
deflection of the cantilever, as can be seen in the withdrawal
portion of the representative force-displacement curve in
Fig. 1 A. The small deflection changes observed over the
course of retraction (zoomed in in the inset of Fig. 1 A)
likely reflect the adhesive force between the silicon canti-
lever and the cell surface as well as the noise of the whole
system. An RGE-coated AFM probe produced no distinct
unbinding features, although the force displacement curve
did show stronger nonspecific interactions between the pep-
tide and the cell membrane, as shown in Fig. 1 B. In contrast,
the RGD-coated AFM probe withdrawal demonstrated
distinct bond rupture events, such as the sudden release of
cantilever bending during retraction shown in Fig. 1 C. In
the representative force curves taken with the RGD-coated
AFM probe, the subsequent unbinding of RGD-integrin RGD
40 pN
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FIGURE 1 No functionalization, nonspecific
binding of RGE versus specific binding of RGD.
(A–C) Single force distance curves between the
AFM tip and the surface of individual cells.
(D–F) Composites of many deflection curves are
represented by affinity probabilities; the single
deflection curves are representative of all subse-
quent data. All Caco-2 cells are assessed with affin-
ity dissociations in Ca2þ- and Mg2þ-free PBS.
(A–C) Only background noise is measured with a
noncoated tip (A) or RGE-coated tip (B), and a
large deflection is noted with RGD coating (C).
The inset in C demonstrates deflection in a step-
wise fashion where clusters of integrins sequen-
tially detach from the RGD-coated tip. Large
incremental changes are produced by clusters of
integrins detaching, and smaller changes are from
smaller clusters or individual integrins. As the
AFM tip withdraws from the surface of the cell,
more and more integrins detach. (C–E) Affinity
probabilities at varying force levels are character-
kground noise is seen in (D), and nonspecific binding is seen with RGE
GD binding characterized by the green curve to the right (F).
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FIGURE 2 Covalent-bond-based functionalization yields a similar result.
(A) A schematic diagram shows the linking process of the RGD sequence
with PEG as crosslinker; the NHS end attaches to the NH2 group on the
cantilever, and the MAL group at the other end links the SATP-modified
RGD sequence. (B) Representative single force distance curves using cova-
lent-bond-based functionalization shows unbinding activities of similar
magnitude in Ca2þ- and Mg2þ-free PBS. The inset shows the magnified un-
binding event. (C) Statistical analysis of binding activity with 300 force
curves shows a specific peak of ~105 pN.
Modulation of Integrin Affinity with AFM Nanorobot 43bond(s)/bond clusters are clearly visible. Precise measure-
ment of the retraction reveals 140 pN or 24 pN force
changes for the two major stepwise deflections, as shown
in the inset of Fig. 1 C. Each individual force measurement
was location and experiment specific, and the largest rupture
events or nonspecific interactions were recorded for each
measurement and translated to create affinity probability
distributions.
Statistical analysis showed that RGE-coated AFM tips
detected a low-deflection-change force-displacement curve
when interacting with the cell surface. This was designated
nonspecific binding, with a peak value of 33.45 0.8 pN in
Fig. 1 E. This peak value is higher than the noise level of
23.0 5 1.3 pN observed using the noncoated AFM tip in
Fig. 1 D. In contrast, the RGD-coated AFM tip interacting
with cell-surface proteins displayed multiple evident un-
binding forces, and a similar bell-shaped curve with a
peak of 55.0 5 3.2 pN was observed. Pattern recognition
showed a Gaussian distribution and another peak with at
115.15 4.9 pN, as shown in Fig. 1 F. This two-peak pattern
is designated the specific activated state when the binding
site for RGD is in an open status.
We also used covalently bonded RGD sequences to mea-
sure the integrin binding force. The covalently bonded probe
was functionalized as described previously (35). Briefly, the
silicon nitride probe was first UV cleaned and then further
cleaned by chloroform. It was then treated with 3-aminopro-
pyltriethoxysilane (APTES) to create the –NH2 on the tip
surface. A heterobifunctional PEG linker molecule was
then able to bind to the –NH2 with the NHS-ester reactive
group. The RGD sequence was modified using N-succini-
midyl 3(-acetylthio)propionate (SATP)). The modification
enabled the binding of the SATP-labeled sequence to the
other end of the PEG linker molecule, maleimide (MAL;
illustrated in Fig. 2 A; the detailed functionalization protocol
can be found in the Supporting Material). The results ob-
tained with this functionalization method (Fig. 2, B and C)
were similar to those obtained by our protocol (26), which
uses probes functionalized with PEG as the noncovalent
linker through which ligands are passively chemisorbed.
Essentially, unbinding forces were detected with the same
magnitude as in Fig. 1 C. A 118 nN snapshot is shown in
Fig. 2 B and magnified in the inset. Statistical analysis
was also performed on 300 force curves obtained at random
positions while Caco-2 cells sat in PBS without Ca2þ and
Mg2þ, the same condition as described in the previous
paragraph (Fig. 1, D–F). A specific binding interaction
peak was clearly observed at ~105 nN (Fig. 2 C), similar
with that shown in Fig. 1 F.Cationic modulation of integrin affinity
Adding Ca2þ or Mg2þ altered the affinities for RGD interac-
tion with the cell membrane. As a control, EDTA chelation
allowed us to measure the integrin-binding force probabili-ties in the absence of divalent extracellular cations. Cationic
chelation yielded a baseline level of interaction force of
65.8 5 2.5 pN (Fig. 3 A). We designated this single peak
interaction in an ion-free environment as the specific inacti-
vated state of integrin binding. With addition of Ca2þ
(1 mM), the binding force was subtly lower than that of
the EDTA control shown in Fig. 3 B, with 56.7 5 2.0 pN,
indicating the capability of this cation in the downregulation
of integrin binding to make a specific inactivated state.
Addition of Mg2þ (1 mM) demonstrated two Gaussian dis-
tribution curves, resulting in a higher average binding force
measurement with two peaks at 50.15 1.1 and 98.95 3.6
pN, respectively (Fig. 3 C), a signature of a specific acti-
vated status. When Ca2þ and Mg2þ were combined at
1 mM each, the binding force remained at baseline measure-
ments (Fig. 3D), with the curve peak at 45.85 1.5 pN. This
is a sign that Ca2þ overtakes Mg2þ in the regulation of integ-
rin, leading to a change in integrin configuration toward a
specific inactivated status.
Quantitating cell adhesion to the type I collagen sub-
strate demonstrated similar findings on a global level.
The EDTA solution acted as control with the baseline
measurements of cell adhesion. Ca2þ at 1 mM showed a
marginal increase in cell adhesion that was not statistically
different from the EDTA control (p ¼ 0.726). Mg2þ signif-
icantly increased the number of remaining cells 2.3-fold
compared with cation chelation with EDTA (p < 0.001)
or Ca2þ treatment (p < 0.001). Finally, Ca2þ and Mg2þ
together at 1 mM had a significantly increased number ofBiophysical Journal 105(1) 40–47
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FIGURE 3 Cation-modulation of integrin affin-
ity for RGD. Caco-2 cells were investigated with
an RGD-coated probe in varying ion-containing
HEPES solutions to develop affinity probability
curves. (A) The cation-chelating agent EDTA in
HEPES solution demonstrates nonspecific binding
when investigated with average binding force of
65.85 2.5 pN. (B) The affinity curve has a slight
rightward shift with higher binding force values
than ion chelation of 56.7 5 2.0 pN, creating a
specific inactivated binding with 1 mM Ca2þ
HEPES solution. (C) Specific activated integrin
binding is demonstrated with 1 mM Mg2þ HEPES
solution with a separate curve above baseline
measurements fitted with the green line at
98.95 3.6 pN. (D) The specific activated binding
of 1 mMMg2þ is antagonized when 1 mM Ca2þ is
present in the HEPES solution with a return to
specific inactivated, or ion-chelated levels. Global
adhesion of Caco-2 cells in the same ion con-
ditions as in A–D demonstrates a nonsignificant increase in adhered cells to type I collagen substrate in Ca2þ, a significant 2.3 increase in adhesion
with Mg2þ, and a significant 0.2 decrease in adherent cells with Ca2þ and Mg2þ together compared with EDTA control (E).
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44 Patterson et al.remaining cells, similar to Mg2þ alone (P < 0.001), but
was nonsignificantly lower than Mg2þ alone (p ¼ 0.631;
data not shown). In contrast, a 10 mM Ca2þ with 1 mM
Mg2þ caused a significantly decreased number of adherent
cells compared with EDTA (p < 0.001), Mg2þ (p ¼ 0.003),
or 1 mM Ca2þ (p ¼ 0.005). These results are summarized
in Fig. 3 E.0.2
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FIGURE 4 FAK modulation of integrin affinity for RGD. (A and B)
Affinity probability curves were developed for Caco-2 cells probed with
an RGD-coated tip in 1 mM Mg2þ HEPES solution and Y15 vehicle (A)
or 20 mMY15 (FAK inhibitor) pretreatment (B). With the vehicle, measure-
ments demonstrate specific-activated binding of RGD-integrin interactions,
fit with the green curve at 103.65 3.7 pN. However, pretreatment with Y15
only shows specific inactivated integrin binding interactions with RGD at
52.3 5 2.1 pN. Similarly to AFM measurement, global cell adhesion
measured the integrin affinity of whole cells for the type I collagen sub-
strate. (C) Compared with the EDTA control, Mg2þ significantly increased
the number of cells that were able to adhere to the substrate 2.3, and Y15
nonsignificantly decreased the ability of Mg2þ-treated cells to adhere. The
Y15 treatment was 1.8 higher than the EDTA control.Intracellular integrin regulation
Mg2þ produced two Gaussian distribution curves similar to
those shown Fig. 3 C when the Y15 vehicle was present
(Fig. 4 A), but the higher binding-affinity curve was abro-
gated by Y15. Mg2þ created an increase in the average
binding force of integrins to 103.6 5 3.7 pN, whereas
Y15 prevented this change and produced a distribution of
affinity probabilities near baseline values and at the same
value as the lower peak of Mg2þ with 52.3 5 2.1 pN
(Fig. 4 B). This is similar in fashion to the Ca2þ and
Mg2þ combination in Fig. 3 D, where the integrins are at
the specific inactivated status. Overall, the cell adhesion
studies showed similar results, i.e., Mg2þ caused a 2.3-
fold increased number of cells to remain attached after
treatment, which is significantly higher than the EDTA-
control (p < 0.001). In addition, Y15 nonsignificantly
reduced the attachment of cells as compared with Mg2þ
with Y15 vehicle (p ¼ 0.347), but still possessed a signif-
icantly higher value than the EDTA control (p< 0.001), as
shown in Fig. 4 C. Y15’s ability to alter FAK phosphoryla-
tion was verified by western blot. After 100 mM Y15 treat-
ment, adherent cells possessed a significantly decreased
amount of phosphorylated FAK as compared with the con-
trol cells exposed only to Y15 vehicle (p ¼ 0.01). The re-
sults of the FAK-blocking western blot can be seen in
Fig. 5, A and B.Biophysical Journal 105(1) 40–47DISCUSSION
In this study, we measured on an individual level (rather
than a global level) the force of attraction between indi-
vidual integrin heterodimers and RGD hexapeptide. We
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FIGURE 5 Western blot of FAK inhibition. The FAK-specific inhibitor
Y15 prevented pressure-induced increases in Caco-2 FAK (Y397) phos-
phorylation. Protein samples from the lysates of Caco-2 cells treated with
100 mM Y15 or control (Y15 vehicle) were directly analyzed by western
blot using phospho-specific antibody to FAK (Y397), as well as antibodies
to FAK. GAPDHwas used as a loading control. (A) Typical blots. (B) Graph
summarizing the densitometric analyses of the ratio of FAK (Y397) phos-
phorylation to total FAK. The level of phosphorylated FAK (pFAK) was
significantly lower in adherent cells with Y15 treatment compared with
the adherent cells of the control group (n ¼ 7, *P ¼ 0.01). All observations
were normalized against control cells.
Modulation of Integrin Affinity with AFM Nanorobot 45objectively defined three integrin-binding states: nonspe-
cific, specific inactivated, and specific activated. Further-
more, we demonstrated directly that both extracellular
cations and intracellular signaling events can specifically
modulate individual integrin heterodimer binding affinity.
The latter, in particular, has only previously been inferred
from indirect evidence (12,36). Finally, our Y15 experi-
ments provide proof of principle that integrin-binding affin-
ity can be directly modulated in intact cells by treatment
with a small-molecule inhibitor.
Lehenkari and Horton’s (26) estimate of the binding affin-
ity of a single RGD-integrin interaction was between 30 and
40 pN, whereas our calculations in a controlled environment
yielded a binding force of 46 5 4.1 pN. Although it is
similar in magnitude, their estimate is 2–3 SDs different
from the binding force we measured. This apparent differ-
ence may be due to the overall system that was employed
for the experiment. We used an AFM-based nanorobotic
system with human-directed precision control to reach any
part of the cell, whereas ordinary AFM systems limit mea-
surements to the spread cell edges. Furthermore, the human
interface via a joystick enables us to survey a greater num-
ber of points covering a larger area, which will effectivelyyield reliable results in situations with nonuniformly distrib-
uted integrin receptors. Certainly, it could also be due to the
calibration of the cantilever spring constants and AFM
detector sensitivity. The differences in individual integrins
and cells may affect cell signaling and cellular structures,
and thus cause variation in the measurements as well.
The result obtained using the covalent-bond functional-
ized probe matches well with that obtained using the chem-
isorbing method, proving the validity of the measurement
result. Similar unbinding forces were recorded using both
methods. The fact that we were able to detect interaction
forces comparable to other published results, and observed
distinct force values demonstrates that the measured force
should represent bond breaking of the receptor-ligand inter-
action, rather than forces uprooting the receptor from the
membrane or dissociating PEG and ligand. Furthermore,
the fact that we were not able to detect any significant inter-
action with the control sequence (RGE), and could modulate
the force by different cation conditions and internal cell
signaling also reinforces the proposition. Thus, to simplify
the process and reduce variability introduced by additional
treatment reagents and processes, we used the protocol re-
ported by Lehenkari and Horton (26) throughout the whole
experiment, and were able to reproduce this key result a
great number of times.
We were able to control for nonspecific protein-lipid and
protein-protein interactions using the uncoated AFM tip and
RGE substitution, respectively. The RGE substitution is a
common control for RGD-related binding (37). Neverthe-
less, integrins tend to cluster in the cell membrane into focal
adhesions, acting together to alter avidity (38), and the AFM
likely interacted with many such integrins at once. Observa-
tions of large incremental drops in adhesive force are due to
the disengagement of bigger groups of integrin-RGD inter-
faces, whereas small changes correlate with smaller clusters
of integrin-RGD interaction detachment. Analysis of the in-
tervals of detachment in each withdrawal of the AFM
defines a lowest common denominator representing the
amount of force of one RGD-integrin interaction.
The bell-shaped distribution of our affinity measurements
requires further comment. There are many different integrin
heterodimers that display a wide range of properties and
functions. Each heterodimer is composed of different pro-
tein structures that may affect the affinity of RGD-integrin
binding (5). Because RGD has been shown to bind to several
heterodimers (5), it is likely that we interacted with more
than one subtype. Therefore, our current results likely reflect
the engagement force of the entire collection of integrins
present in Caco-2 cells that can bind to RGD peptides.
Furthermore, our use of random surface sampling with the
AFM probe means it is equally likely that we encountered
the center of the cell versus the periphery. To elaborate,
focal adhesions have a location-dependent composition
(39). For instance, a given focal adhesion complex may
have different integrin heterodimer combinations at theBiophysical Journal 105(1) 40–47
46 Patterson et al.cell edges compared with the body of the cell, leading to a
difference in binding values. These factors likely contrib-
uted to the Gaussian distribution of binding affinities in
our results.
EDTA and Ca2þ produced similar but differently distrib-
uted baseline binding force curves, suggesting that they sup-
press full integrin-RGD interactions. Mg2þ supplementation
yielded a large, rightward-shifted binding curve. This is
consistent with the concept that occupation of the divalent
cation-binding site on the extracellular domain of the b1 in-
tegrin subunit by magnesium cations can alter integrin ter-
tiary and quaternary structure to expose or enhance the
binding affinity of the RGD-binding site jointly specified
by both the b and a integrin subunits (3,40). Adding Ca2þ
along with Mg2þ suppressed this rightward shift; in this
case, Ca2þ acted as an antagonist of Mg2þ. Our global
assays of cell adhesion used 10 mM Ca2þ with 1 mM
Mg2þ instead of 1 mM Ca2þ because we were not able to
demonstrate a statistically significant decrease with 1 mM
Ca2þ. In contrast, the AFM measurements were more sensi-
tive and were able to detect significant antagonism between
1 mM Ca2þ and 1 mMMg2þ together. This suggests that the
AFM technique is sensitive for measuring effects on these
nanoscale forces of protein-protein interactions.
Y15 blocks FAK phosphorylation and its consequent acti-
vation, and has been reported to decrease cell attachment to
its substrate (17). FAK inhibition by Y15 was able to modu-
late the affinity of individual integrins. Indeed, Y15 in-
hibited the second binding peak that Mg2þ promotes. FAK
activity is classically modulated by integrin signaling after
engagement with matrix proteins (41), but our results
clearly define the other side of a feedback loop in
which FAK in turn modulates integrin-binding affinity for
the ECM.
Despite the heterogeneity and distribution of the integ-
rins, we were able to manipulate the status of the integrins
expressed by the cells together, as evidenced by the overall
rightward shift in the curve distribution, and the three states
of integrin binding that could be achieved (nonspecific, spe-
cific inactivated, and specific activated). Our ion-chelation
studies demonstrated nonspecific binding of the RGD-
coated AFM tip with the cell. The studies with Ca2þ
treatment or the FAK inhibitor demonstrated a specific inac-
tivated binding state of integrins, whereas the studies with
Mg2þ supplementation demonstrated specific activated in-
tegrin binding. Importantly, different conformations of the
integrin may still bind ligands such as RGD, even in the
closed state (42,43). Different ions and intracellular signals
are known to change the conformation of integrins (38,44).
Therefore, we actually bound integrins in different states
and measured the properties in these critically important
conditions. This is consistent with previous studies suggest-
ing that multiple forms of integrin conformation lead to
ligand affinity changes (44). In addition, the overall
breaking point of the integrin-RGD interactions varies de-Biophysical Journal 105(1) 40–47pending on the number of integrins that are bound to the
tip: the single integrin-binding force, determined statisti-
cally, differed among the three states. Each state had a
different individual binding force that correlated with the
curve distributions. The number of clusters that unbound
in stepwise fashion, however, did not have a discernible
pattern among the integrin states.
Understanding these molecular-level forces may allow us
to further understand and evaluate a cell’s interaction with
its environment. Furthermore, this allows for molecular
and global studies in this field combined with a clinical
setting, as cations have been shown to affect colon cancer
and adhesion (45). In addition, FAK has been implicated
in cancer states, and treatments are currently being explored
(46,47). Future directions include the exploration of integrin
affinity modulation in the context of disease states. It will be
especially important to explore changes on the individual in-
tegrin level that lead to a global cell change, which will
allow us to understand the nature of cell-ECM interactions.
The in situ screening of live cells enabled by the AFM-based
nanorobot could be an important tool for elucidating how
cells adhere in vivo during processes as diverse as develop-
mental migration, inflammation, and metastasis.SUPPORTING MATERIAL
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